{{Rsnum
|rsid=998424
|Gene=SLC6A2
|Chromosome=16
|position=55698034
|Orientation=minus
|GMAF=0.2681
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC6A2
}}{{PMID|17994190}} Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and [[attention-deficit/hyperactivity disorder]] symptoms in adults.

{{PMID|17876324}}Further evidence of association between two NET single-nucleotide polymorphisms with [[ADHD]].

{{PMID|20863575}}Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD.

{{PMID|21122117|OA=1
}} Genetic influences on attention deficit hyperactivity disorder symptoms from age 2 to 3: a quantitative and molecular genetic investigation.

{{PMID|15717291}} Support for association between ADHD and two candidate genes: NET1 and DRD1.

{{PMID Auto
|PMID=18937296
|Title=Replication of a rare protective allele in the noradrenaline transporter gene and ADHD.
|OA=1
}}

{{PMID Auto
|PMID=18937309
|Title=Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study.
|OA=1
}}

{{PMID Auto
|PMID=19693267
|Title=Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene.
|OA=1
}}

{{PMID Auto
|PMID=19721846
|Title=Candidate genes involved in neural plasticity and the risk for attention-deficit hyperactivity disorder: a meta-analysis of 8 common variants.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}